KOD · Kodiak Sciences Inc.
$40.04
-0.26 (-0.63%)
At close · Jul 29
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our financial condition raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$2.52B
Shares
62.58M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$40.29
Open$42.23
Day$38.86–42.59
52W$6.21–47.84
Avg vol 30d771K
Short int10.4M · 16.6% float · 13.7d
Short vol66%
Last earningsNov 13, 2025
DataJan 2020–Jul 2026
Filing10-Q · May 7
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+35%
above
Price vs 50-day avg
+9%
above
RSI (14)
52
neutral
MACD trend
Negative
52-week position
82%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+12%
trailing
6-month return
+67%
trailing
YTD return
+44%
this year
Relative strength
+60%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $37 › 200d $30 — 50d above 200d
Institutional flow
Accumulating
26 of 190 funds reported for Jun 30 · net +18.6K sh shares · +2 new
Insider flow
Distributing
Net -$1.0M over 90 days · 100% sells
Short interest
Falling
16.64% of float · ▼ -2.0% MoM · 13.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
190 holders — near 3-yr high, broad support
Squeeze score
82
high risk · 0–100
Fundamentals
EPS growth
−29%
Y/Y
Free cash flow
$-136.5M
Balance sheet
$209.9M
net cash
Quant / Vol
risk profile
Volatility
132%
annualized · 1-yr
Max drawdown
−37%
past year
ATR
7.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+35%
Bullish
Price vs 50-day avg
+9%
Bullish
RSI (14)
52
Neutral
MACD trend
Negative
Bearish
52-week position
82%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $37 › 200d $30 — 50d above 200d
Institutional flow
Accumulating
26 of 190 funds reported for Jun 30 · net +18.6K sh shares · +2 new
Insider flow
Distributing
Net -$1.0M over 90 days · 100% sells
Short interest
Falling
16.64% of float · ▼ -2.0% MoM · 13.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
190 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $6
Now $40 · 82%
52-wk high $48
vs 200-day avg +35%
vs 50-day avg +9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| DAYBREAK Phase 3 study enrollment | 690 | first quarter 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KOD
this stock
Kodiak Sciences Inc.
|
$2.52B | +44.1% | — | — | 16.6% |
|
ONC
BeOne Medicines Ltd.
|
$472.90B | +8.8% | +22179.2% | 962.4 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$124.46B | +8.2% | +46.2% | 29.1 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$72.88B | -9.8% | +20.8% | 17.0 | 3.3% |
|
ARGX
Argenx SE
|
$54.57B | +3.7% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KOD | -1.4% | +12.1% | +67.1% | +3.4% | +44.1% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -0.4% | +12.1% | +59.7% | +4.2% | +35.5% |